Publication related to RSI or an RSI staff member

Magnetic resonance imaging T1 indices of the brain as biomarkers of inhaled manganese exposure.

Excessive exposure to manganese (Mn) is linked to its accumulation in the brain and adverse neurological effects. Paramagnetic properties of Mn allow the use of magnetic resonance imaging (MRI) techniques to identify it in biological tissues. A critical review was conducted to evaluate whether MRI techniques could be used as a diagnostic tool to detect brain Mn accumulation as a quantitative biomarker of inhaled exposure. A comprehensive search was conducted in MEDLINE, EMBASE, and PubMed to identify potentially relevant studies published prior to 9 May 2022. Two reviewers independently screened identified references using a two-stage process. Of the 6452 unique references identified, 36 articles were retained for data abstraction. Eligible studies used T1-weighted MRI techniques and reported direct or indirect T1 measures to characterize Mn accumulation in the brain. Findings demonstrate that, in subjects exposed to high levels of Mn, deposition in the brain is widespread, accumulating both within and outside the basal ganglia. Available evidence indicates that T1 MRI techniques can be used to distinguish Mn-exposed individuals from unexposed. Additionally, T1 MRI may be useful for semi-quantitative evaluation of inhaled Mn exposure, particularly when interpreted along with other exposure indices. T1 MRI measures appear to have a nonlinear relationship to Mn exposure duration, with R1 signal only increasing after critical thresholds. The strength of the association varied depending on the regions of interest imaged and the method of exposure measurement. Overall, available evidence suggests potential for future clinical and risk assessment applications of MRI as a diagnostic tool.

Authors

  • Jensen, N, Jensen N, Risk Sciences International, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

  • Terrell, R, Terrell R, Risk Sciences International, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

  • Ramoju, S, Ramoju S, Risk Sciences International, Ottawa, Canada.

  • Shilnikova, N, Shilnikova N, Risk Sciences International, Ottawa, Canada.; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Canada.

  • Farhat, N, Farhat N, Risk Sciences International, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.; School of Mathematics and Statistics, Carleton University, Ottawa, Canada.

  • Karyakina, N, Karyakina N, Risk Sciences International, Ottawa, Canada.; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Canada.

  • Cline, B H, Cline BH, International Manganese Institute, Paris, France.

  • Momoli, F, Momoli F, Risk Sciences International, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

  • Mattison, D, Mattison D, Risk Sciences International, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.; Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.

  • Krewski, D, Krewski D, Risk Sciences International, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Canada.; School of Mathematics and Statistics, Carleton University, Ottawa, Canada.

YEAR OF PUBLICATION: 2022
SOURCE: Crit Rev Toxicol. 2022 May;52(5):358-370. doi: 10.1080/10408444.2022.2128719. Epub 2022 Nov 22.
JOURNAL TITLE ABBREVIATION: Crit Rev Toxicol
JOURNAL TITLE: Critical reviews in toxicology
ISSN: 1547-6898 (Electronic) 1040-8444 (Linking)
VOLUME: 52
ISSUE: 5
PAGES: 358-370
PLACE OF PUBLICATION: England
ABSTRACT:
Excessive exposure to manganese (Mn) is linked to its accumulation in the brain and adverse neurological effects. Paramagnetic properties of Mn allow the use of magnetic resonance imaging (MRI) techniques to identify it in biological tissues. A critical review was conducted to evaluate whether MRI techniques could be used as a diagnostic tool to detect brain Mn accumulation as a quantitative biomarker of inhaled exposure. A comprehensive search was conducted in MEDLINE, EMBASE, and PubMed to identify potentially relevant studies published prior to 9 May 2022. Two reviewers independently screened identified references using a two-stage process. Of the 6452 unique references identified, 36 articles were retained for data abstraction. Eligible studies used T1-weighted MRI techniques and reported direct or indirect T1 measures to characterize Mn accumulation in the brain. Findings demonstrate that, in subjects exposed to high levels of Mn, deposition in the brain is widespread, accumulating both within and outside the basal ganglia. Available evidence indicates that T1 MRI techniques can be used to distinguish Mn-exposed individuals from unexposed. Additionally, T1 MRI may be useful for semi-quantitative evaluation of inhaled Mn exposure, particularly when interpreted along with other exposure indices. T1 MRI measures appear to have a nonlinear relationship to Mn exposure duration, with R1 signal only increasing after critical thresholds. The strength of the association varied depending on the regions of interest imaged and the method of exposure measurement. Overall, available evidence suggests potential for future clinical and risk assessment applications of MRI as a diagnostic tool.
LANGUAGE: eng
DATE OF PUBLICATION: 2022 May
DATE OF ELECTRONIC PUBLICATION: 20221122
DATE COMPLETED: 20221219
DATE REVISED: 20230129
MESH DATE: 2022/12/20 06:00
EDAT: 2022/11/23 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: 10.1080/10408444.2022.2128719 [doi]
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski

Donald Mattison

Chief Medical Officer, Senior Vice-President

Dr. Donald Mattison joined Risk Sciences International (RSI) in 2012 as Senior Vice-President and Chief Medical Officer, bringing with him a distinguished career spanning public health, clinical medicine, toxicology, and academic leadership. His appointment significantly strengthened RSI’s capacity to deliver...
Read More about Donald Mattison

Franco Momoli

Vice-President Chemical and Product Safety

Dr. Franco Momoli joined Risk Sciences International (RSI) in 2019 and currently serves as Vice-President, Chemical and Product Safety. In this role, he leads a multidisciplinary team of epidemiologists, risk assessors, toxicologists, and biostatisticians in conducting human health risk assessments...
Read More about Franco Momoli

Nataliya Karyakina

Senior Toxicologist, Health Risk Analyst

Dr. Nataliya Karyakina is a Senior Toxicologist and Health Risk Analyst at Risk Sciences International (RSI), where she has served since 2008. She plays a central role in RSI’s work at the intersection of chemical safety, regulatory science, and human...
Read More about Nataliya Karyakina

Natalia (Natasha) Shilnikova

Senior Health Risk Analyst

Dr. Natalia (Natasha) Shilnikova is a Senior Health Risk Analyst at Risk Sciences International (RSI), where she has contributed since 2011 to some of the organization’s most analytically demanding and policy-relevant projects. With a background in medicine and a PhD...
Read More about Natalia (Natasha) Shilnikova